Neuromuscular Blockade: Difference between revisions
No edit summary |
No edit summary |
||
Line 48: | Line 48: | ||
[https://pubmed.ncbi.nlm.nih.gov/35188958/ Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative] | [https://pubmed.ncbi.nlm.nih.gov/35188958/ Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative] | ||
[https://pubmed.ncbi.nlm.nih.gov/26646837/ Sugammadex and rocuronium-induced anaphylaxis] |
Revision as of 18:56, 6 March 2023
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
Encapsulation dynamics of neuromuscular blocking drugs by sugammadex
Neuromuscular blockade in children
Test Your Knowledge: unique advantage of rocuronium
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
Sugammadex and rocuronium-induced anaphylaxis
Pseudocholinesterase Deficiency
Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury
Quantitative Neuromuscular Monitoring and Postoperative Outcomes: A Narrative Review
Neuromuscular Monitoring in the Perioperative Period
Intraoperative neuromuscular monitoring site and residual paralysis